Literature DB >> 15057091

The use of tapered stems for femoral revision surgery.

Paul Böhm1, Oliver Bischel.   

Abstract

From a biomechanical view point, cementless fixation of a tapered stem has some advantages compared with other techniques to treat severe proximal femoral bone loss in reconstructive hip surgery. We reviewed 129 consecutive revision arthroplasties of the femoral component in which the tapered Wagner self-locking revision stem was used. The mean followup of patients without rerevision of the stem was 8.1 years (range, 5.1-14.1 years). Six revision stems required rerevision (malpositioning, one stem; subsidence, one stem; periprosthetic fracture, one stem; deep infection, three stems) between 0.13 and 4.6 years postoperatively. Using removal of the stem for any cause as the end point, the cumulative survival at 14.1 years was 95.2%. The average Merle d'Aubigné score improved from 7.7 points preoperatively to 14.4 points at the latest followup. Because of new bone formation, the most recent radiographs showed clear, good, or excellent restoration of the proximal femur in 88% of patients. Considering possible late complications such as osteolysis of the femur, aseptic loosening, periprosthetic fracture, and late infection, the shortest stem that ensures sufficient mechanical stability should be used. It may be easier to achieve high primary stability in short stems with a tapered design than with other short stem designs.

Entities:  

Mesh:

Year:  2004        PMID: 15057091

Source DB:  PubMed          Journal:  Clin Orthop Relat Res        ISSN: 0009-921X            Impact factor:   4.176


  26 in total

1.  [Cementless stems of the hip. Current status].

Authors:  H Effenberger; M Imhof; U Witzel; S Rehart
Journal:  Orthopade       Date:  2005-05       Impact factor: 1.087

2.  Are short fully coated stems adequate for "simple" femoral revisions?

Authors:  Matthew W Tetreault; Sanjai K Shukla; Paul H Yi; Scott M Sporer; Craig J Della Valle
Journal:  Clin Orthop Relat Res       Date:  2014-02       Impact factor: 4.176

3.  The long modified extended sliding trochanteric osteotomy.

Authors:  Dror Lakstein; Yona Kosashvili; David Backstein; Oleg Safir; Paul Lee; Allan E Gross
Journal:  Int Orthop       Date:  2009-10-16       Impact factor: 3.075

4.  Femoral revision hip arthroplasty: a comparison of two stem designs.

Authors:  Corey J Richards; Clive P Duncan; Bassam A Masri; Donald S Garbuz
Journal:  Clin Orthop Relat Res       Date:  2010-02       Impact factor: 4.176

Review 5.  Femoral revision with primary cementless stems: a systematic review of the literature.

Authors:  Luca Cavagnaro; Matteo Formica; Marco Basso; Andrea Zanirato; Stefano Divano; Lamberto Felli
Journal:  Musculoskelet Surg       Date:  2017-07-01

6.  Revision total hip arthroplasty using a cementless tapered revision stem in patients with a mean age of 82 years.

Authors:  Daniel Neumann; Lothar Dueckelmann; Christoph Thaler; Ulrich Dorn
Journal:  Int Orthop       Date:  2011-10-26       Impact factor: 3.075

7.  Revision hip arthroplasty with a rectangular tapered cementless stem: a retrospective study of the SLR-Plus stem at a mean follow-up of 4.1 years.

Authors:  Iker Uriarte; Jesús Moreta; Laura Cortés; Lucía Bernuy; Urko Aguirre; José Luis Martínez de Los Mozos
Journal:  Eur J Orthop Surg Traumatol       Date:  2019-10-15

8.  Revision total hip arthroplasty with a porous-coated modular stem: 5 to 10 years follow-up.

Authors:  Dror Lakstein; David Backstein; Oleg Safir; Yona Kosashvili; Allan E Gross
Journal:  Clin Orthop Relat Res       Date:  2009-06-16       Impact factor: 4.176

9.  Modular tapered implants for severe femoral bone loss in THA: reliable osseointegration but frequent complications.

Authors:  Nicholas M Brown; Matthew Tetreault; Cara A Cipriano; Craig J Della Valle; Wayne Paprosky; Scott Sporer
Journal:  Clin Orthop Relat Res       Date:  2015-02       Impact factor: 4.176

10.  Stem modularity alone is not effective in reducing dislocation rate in hip revision surgery.

Authors:  Dario Regis; Andrea Sandri; Pietro Bartolozzi
Journal:  J Orthop Traumatol       Date:  2009-11-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.